Top compounds associated with response to LINC01125


Feature Type Standardized
Nominal ANOVA
mRNA PD318088 CTRPv2 pan-cancer AAC -0.11 0.002
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.11 0.002
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.11 0.002
mRNA tacedinaline CTRPv2 pan-cancer AAC 0.12 0.003
mRNA BRD-A71883111 CTRPv2 pan-cancer AAC 0.11 0.003
mRNA prima-1 CTRPv2 pan-cancer AAC 0.095 0.003
mRNA Cerulenin CTRPv2 pan-cancer AAC 0.099 0.003
mRNA indisulam CTRPv2 pan-cancer AAC 0.095 0.003
mRNA pluripotin CTRPv2 pan-cancer AAC -0.1 0.004
mRNA piperlongumine CTRPv2 pan-cancer AAC 0.091 0.005
Download CSV